diphosphoric acid has been researched along with Myasthenia Gravis in 4 studies
diphosphoric acid : An acyclic phosphorus acid anhydride obtained by condensation of two molecules of phosphoric acid.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HARVEY, AM | 1 |
GOTZE, W | 1 |
OSSERMAN, KE | 1 |
KAPLAN, LI | 1 |
PASSOUANT, P | 1 |
LEVY, A | 1 |
4 other studies available for diphosphoric acid and Myasthenia Gravis
Article | Year |
---|---|
Some physiological experiments of nature in the field of neuromuscular function; tetra-ethyl pyrophosphate in the treatment of myasthenia gravis, potassium deficiency, potassium intoxication.
Topics: Animals; Characidae; Diphosphates; Drug-Related Side Effects and Adverse Reactions; Hypokalemia; Mya | 1948 |
[Experience in therapy of myasthenia with tetraisopropyl pyrophosphate (myastenol)].
Topics: Diphosphates; Muscle Weakness; Myasthenia Gravis | 1952 |
Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA).
Topics: Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds | 1954 |
[Tetra-ethyl-pyrophosphate in the treatment of myasthenia; study of blood cholinesterase].
Topics: Animals; Characidae; Cholinesterases; Diphosphates; Humans; Muscle Weakness; Myasthenia Gravis | 1951 |